featured
Lenalidomide Maintenance vs Observation for Patients With Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenalidomide Maintenance Versus Observation for Patients With Newly Diagnosed Multiple Myeloma (Myeloma XI): A Multicentre, Open-Label, Randomised, Phase 3 Trial
Lancet Oncol 2018 Dec 14;[EPub Ahead of Print], GH Jackson, FE Davies, C Pawlyn, DA Cairns, A Striha, C Collett, A Hockaday, JR Jones, B Kishore, M Garg, CD Williams, K Karunanithi, J Lindsay, MW Jenner, G Cook, NH Russell, MF Kaiser, MT Drayson, RG Owen, WM Gregory, GJ MorganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.